Metformin may modulate inflammation by ameliorating hyperglycemia and through an 5’ adenosine monophosphate-activated protein kinase-dependent modulation of the mammalian target of rapamycin and the signal transducer and activator of transcription 3 and 5 of T-cells (46). Here, MTOR is linked to Hyperglycemia.